DRISCOLL FREDERICK W has filed 7 insider transactions across 3 companies since June 2023.
Most recent transaction: a grant/award of 55000 shares of Lite Strategy, Inc. ($LITS) on November 14, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 14, 2025 | Lite Strategy, Inc. | $LITS | DRISCOLL FREDERICK W | Not found | A | Stock Option (Right to Buy) | 55000 | $0.00 | 55,000.0000 | 36,785,397 | 9999.99% | 0.15% |
| July 15, 2025 | Lite Strategy, Inc. | $LITS | DRISCOLL FREDERICK W | Not found | A | Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 6,663,000 | 9999.99% | 0.30% |
| Feb. 14, 2025 | Cellectar Biosciences, Inc. | $CLRB | DRISCOLL FREDERICK W | Director | A | Stock option (right to buy) | 60000 | $0.00 | 60,000.0000 | 1,238,125 | 9999.99% | 4.85% |
| Jan. 2, 2025 | Cue Biopharma, Inc. | $CUE | DRISCOLL FREDERICK W | Not found | A | Stock Option (right to buy) | 24400 | $0.00 | 24,400.0000 | 56,328,348 | 9999.99% | 0.04% |
| June 14, 2024 | Cellectar Biosciences, Inc. | $CLRB | DRISCOLL FREDERICK W | Director | A | Stock option (right to buy) | 60000 | $0.00 | 60,000.0000 | 29,346,679 | 9999.99% | 0.20% |
| Jan. 2, 2024 | Cue Biopharma, Inc. | $CUE | DRISCOLL FREDERICK W | Not found | A | Stock Option (right to buy) | 24400 | $0.00 | 24,400.0000 | 45,754,794 | 9999.99% | 0.05% |
| June 28, 2023 | Cellectar Biosciences, Inc. | $CLRB | DRISCOLL FREDERICK W | Director | A | Stock option (right to buy) | 25000 | $0.00 | 47,650.0000 | 11,261,217 | 110.38% | 0.22% |